BlossomHill Therapeutics
ApprovedWe are building on our team’s exceptional track record of FDA-approved precision medicines to create the next leap forward in oncology and autoimmune diseases.
Founded
2018
Focus
Small Molecules
About
We are building on our team’s exceptional track record of FDA-approved precision medicines to create the next leap forward in oncology and autoimmune diseases.
Funding History
2Total raised: $250M
Series B$150MCormorant Asset ManagementJul 15, 2023
Series A$100MCormorant Asset ManagementJan 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile